Regular papers

• Select this article
  • Atsushi Mizokami,
  • Eitetsu Koh,
  • Kouji Izumi,
  • Kazutaka Narimoto,
  • Masashi Takeda,
  • Seijiro Honma,
  • Jinlu Dai,
  • Evan T Keller,
  • and Mikio Namiki

  Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone

  Endocr Relat Cancer 16 (4) 1139-1155, doi:10.1677/ERC-09-0070 first published on 16 July 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • D Alwyn Dart,
  • Bradley Spencer-Dene,
  • Simon C Gamble,
  • Jonathan Waxman,
  • and Charlotte L Bevan

  Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours

  Endocr Relat Cancer 16 (4) 1157-1169, doi:10.1677/ERC-09-0028 first published on 27 July 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Supplementary Data

  OPEN ACCESS ARTICLE
• Select this article
  • Yong Lu,
  • Didier J L Mekoo,
  • Kedong Ouyang,
  • Xiangbing Hu,
  • Yanhua Liu,
  • Ming Lin,
  • Liang Jin,
  • Rongyue Cao,
  • Taiming Li,
  • Yankai Zhang,
  • Hao Fan,
  • and Jingjing Liu

  Strong humoral response elicited by a DNA vaccine targeting gastrin-releasing peptide with optimized adjuvants inhibits murine prostate carcinoma growth in vivo

  Endocr Relat Cancer 16 (4) 1171-1184, doi:10.1677/ERC-09-0058 first published on 31 July 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Céline Van Themsche,
  • Sophie Parent,
  • Valérie Leblanc,
  • Caroline Descôteaux,
  • Anne-Marie Simard,
  • Gervais Bérubé,
  • and Eric Asselin

  VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo

  Endocr Relat Cancer 16 (4) 1185-1195, doi:10.1677/ERC-09-0113 first published on 6 August 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • T Jardé,
  • F Caldefie-Chézet,
  • N Goncalves-Mendes,
  • F Mishellany,
  • C Buechler,
  • F Penault-Llorca,
  • and M P Vasson

  Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies

  Endocr Relat Cancer 16 (4) 1197-1210, doi:10.1677/ERC-09-0043 first published on 6 August 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • V Häyry,
  • K Salmenkivi,
  • J Arola,
  • P Heikkilä,
  • C Haglund,
  • and H Sariola

  High frequency of SNAIL-expressing cells confirms and predicts metastatic potential of phaeochromocytoma

  Endocr Relat Cancer 16 (4) 1211-1218, doi:10.1677/ERC-09-0049 first published on 29 July 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • A M Schmitt,
  • S Schmid,
  • T Rudolph,
  • M Anlauf,
  • C Prinz,
  • G Klöppel,
  • H Moch,
  • P U Heitz,
  • P Komminoth,
  • and A Perren

  VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors

  Endocr Relat Cancer 16 (4) 1219-1227, doi:10.1677/ERC-08-0297 first published on 18 August 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Silvia Darb-Esfahani,
  • Ralph M Wirtz,
  • Bruno V Sinn,
  • Jan Budczies,
  • Aurelia Noske,
  • Wilko Weichert,
  • Areeg Faggad,
  • Susanne Scharff,
  • Jalid Sehouli,
  • Guelten Oskay-Özcelik,
  • Claudio Zamagni,
  • Pierandrea De Iaco,
  • Andrea Martoni,
  • Manfred Dietel,
  • and Carsten Denkert

  Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue

  Endocr Relat Cancer 16 (4) 1229-1239, doi:10.1677/ERC-08-0338 first published on 12 August 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Claudio Zamagni,
  • Ralph M Wirtz,
  • Pierandrea De Iaco,
  • Marta Rosati,
  • Elke Veltrup,
  • Federica Rosati,
  • Elisa Capizzi,
  • Nicoletta Cacciari,
  • Carlo Alboni,
  • Alessandra Bernardi,
  • Francesco Massari,
  • Sara Quercia,
  • Antonietta D'Errico Grigioni,
  • Manfred Dietel,
  • Jalid Sehouli,
  • Carsten Denkert,
  • and Andrea Angelo Martoni

  Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies

  Endocr Relat Cancer 16 (4) 1241-1249, doi:10.1677/ERC-08-0342 first published on 11 September 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • E Fiore,
  • T Rago,
  • M A Provenzale,
  • M Scutari,
  • C Ugolini,
  • F Basolo,
  • G Di Coscio,
  • P Berti,
  • L Grasso,
  • R Elisei,
  • A Pinchera,
  • and P Vitti

  Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role

  Endocr Relat Cancer 16 (4) 1251-1260, doi:10.1677/ERC-09-0036 first published on 15 June 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Nabahet Ameur,
  • Ludovic Lacroix,
  • Sophie Roucan,
  • Véronique Roux,
  • Sophie Broutin,
  • Monique Talbot,
  • Corinne Dupuy,
  • Bernard Caillou,
  • Martin Schlumberger,
  • and Jean-Michel Bidart

  Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways

  Endocr Relat Cancer 16 (4) 1261-1272, doi:10.1677/ERC-08-0289 first published on 12 August 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Yu-fang Bi,
  • Rui-xin Liu,
  • Lei Ye,
  • Hai Fang,
  • Xiao-ying Li,
  • Wei-qing Wang,
  • Ji Zhang,
  • Kan-Kan Wang,
  • Lei Jiang,
  • Ting-wei Su,
  • Zhong-yuan Chen,
  • and Guang Ning

  Gene expression profiles of thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome reveal novel molecular mechanism

  Endocr Relat Cancer 16 (4) 1273-1282, doi:10.1677/ERC-08-0325 first published on 22 July 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Heribert Hänscheid,
  • Michael Lassmann,
  • Markus Luster,
  • Richard T Kloos,
  • and Christoph Reiners

  Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma

  Endocr Relat Cancer 16 (4) 1283-1289, doi:10.1677/ERC-09-0076 first published on 23 July 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Andreas Machens,
  • Florian Hoffmann,
  • Carsten Sekulla,
  • and Henning Dralle

  Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer

  Endocr Relat Cancer 16 (4) 1291-1298, doi:10.1677/ERC-09-0136 first published on 2 September 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
• Select this article
  • Alessandro Antonelli,
  • Silvia Martina Ferrari,
  • Poupak Fallahi,
  • Silvia Frascerra,
  • Simona Piaggi,
  • Stefania Gelmini,
  • Cristiana Lupi,
  • Michele Minuto,
  • Piero Berti,
  • Salvatore Benvenga,
  • Fulvio Basolo,
  • Claudio Orlando,
  • and Paolo Miccoli

  Dysregulation of secretion of CXC α-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-γ agonists

  Endocr Relat Cancer 16 (4) 1299-1311, doi:10.1677/ERC-08-0337 first published on 15 September 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Brian Harding,
  • Manuel C Lemos,
  • Anita A C Reed,
  • Gerard V Walls,
  • Jeshmi Jeyabalan,
  • Michael R Bowl,
  • Hilda Tateossian,
  • Nicky Sullivan,
  • Tertius Hough,
  • William D Fraser,
  • Olaf Ansorge,
  • Michael T Cheeseman,
  • and Rajesh V Thakker

  Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia

  Endocr Relat Cancer 16 (4) 1313-1327, doi:10.1677/ERC-09-0082 first published on 20 July 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • D Dworakowska,
  • E Wlodek,
  • C A Leontiou,
  • S Igreja,
  • M Cakir,
  • M Teng,
  • N Prodromou,
  • M I Góth,
  • S Grozinsky-Glasberg,
  • M Gueorguiev,
  • B Kola,
  • M Korbonits,
  • and A B Grossman

  Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors

  Endocr Relat Cancer 16 (4) 1329-1338, doi:10.1677/ERC-09-0101 first published on 20 July 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • C Schaaf,
  • B Shan,
  • M Buchfelder,
  • M Losa,
  • J Kreutzer,
  • W Rachinger,
  • G K Stalla,
  • T Schilling,
  • E Arzt,
  • M J Perone,
  • and U Renner

  Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo

  Endocr Relat Cancer 16 (4) 1339-1350, doi:10.1677/ERC-09-0129 first published on 2 September 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Laetitia Dahan,
  • Frank Bonnetain,
  • Philippe Rougier,
  • Jean-Luc Raoul,
  • Eric Gamelin,
  • Pierre-Luc Etienne,
  • Guillaume Cadiot,
  • Emmanuel Mitry,
  • Denis Smith,
  • Frédérique Cvitkovic,
  • Bruno Coudert,
  • Floriane Ricard,
  • Laurent Bedenne,
  • Jean-François Seitz,
  • and for the Fédération Francophone de Cancérologie Digestive (FFCD) and the Digestive Tumors Group of the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)

  Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon α for advanced carcinoid tumors: FNCLCC–FFCD 9710

  Endocr Relat Cancer 16 (4) 1351-1361, doi:10.1677/ERC-09-0104 first published on 2 September 2009
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only